The DEA has published a notice of intent to place the synthetic opioid brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) in Schedule I under the agency’s emergency temporary scheduling authority (85 Fed. Reg. 78047, Dec. 3, 2020). The agency’s notice of intent states that the substance is being found in illicit channels in a manner simil... Read More